The news world is saturated with the significant number of deaths linked to COVID-19 since the start of 2020, but cancer is still the leading cause of premature death in France by far (source: Public Health France). More than 150,000 people die each year from this disease. To help provide better treatment outcomes for these patients, French company Nanobiotix offers cutting-edge technology that seeks to revolutionize cancer treatment using nanophysics.
This company, whose market capitalization exceeded 180 million euros in August 2020, is constantly looking to undertake new therapeutic feats. The floor was given to the co-founder and CEO of Nanobiotix, Laurent Levy, to discuss this French innovation within our Blasting Talks project, which consists of focusing on the challenges that companies face during the evolution of the digital world and during this unprecedented period of health crisis.